Brian T Hopkins

USPTO Granted Patents = 32 (Patent Applications = 17)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 15 (Patent Applications = 25)

Average Co-Inventor Count = 8.9

ph-index = 7

Forward Citations = 111(Granted Patents)

Location History:

Brookline, MA (US) (2010)
Newton, MA (US) (2011 - 2024)

Company Filing History:

Sunesis Pharmaceuticals, Inc.

patents

4 out of 108

Infinity Pharmaceuticals, Inc.

patents

4. 3 out of 12

Infinity Discovery, Inc.

6. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

32 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12391697 - Condensed bi-heterocycles as inhibiting agents for Bruton's tyrosine kinase (2025-08-19),

2. 12240838 - Inhibiting agents for Bruton's tyrosine kinase (2025-03-04),

3. 11858926 - Inhibiting agents for bruton's tyrosine kinase (2024-01-02),

4. 11572356 - Biaryl inhibitors of Bruton's tyrosine kinase (2023-02-07),

5. 11427577 - Inhibiting agents for Bruton's tyrosine kinase (2022-08-30),

6. 10961237 - Inhibiting agents for Bruton's tyrosine kinase (2021-03-30),

7. 10899753 - Inhibiting agents for Bruton's tyrosine kinase (2021-01-26),

8. 10759783 - Biaryl inhibitors of Bruton'S tyrosine kinase (2020-09-01),

9. 10618887 - Pyrimidinyl tyrosine kinase inhibitors (2020-04-14),

10. 10577374 - Bruton's tyrosine kinase inhibitors (2020-03-03),

11. 10280169 - Biaryl bruton's tyrosine kinase inhibitors (2019-05-07),

12. 10227341 - Inhibiting agents for bruton's tyrosine kinase (2019-03-12),

13. 10189829 - Inhibiting agents for Bruton's tyrosine kinase (2019-01-29),

14. 10189817 - Inhibitors of Bruton's tyrosine kinase (2019-01-29),

15. 10081619 - Biaryl inhibitors of bruton's tyrosine kinase (2018-09-25),

Title: Brian T. Hopkins: A Pioneer in Pharmaceutical Innovations

Introduction: Brian T. Hopkins, based in Newton, MA, is an accomplished inventor with a remarkable portfolio of 31 patents. His contributions to the field of pharmaceuticals have been significant, particularly in the development of inhibiting agents aimed at targeting Bruton's tyrosine kinase, a crucial enzyme involved in various diseases.

Latest Patents: Among his most recent patents are innovative compounds for inhibiting Bruton's tyrosine kinase. These patents are centered around compounds of Formula (I), including pharmaceutically acceptable salts, and elaborate on methods for their usage and production. This groundbreaking work positions Hopkins as a leading figure in developing therapies for conditions influenced by this enzyme.

Career Highlights: Throughout his career, Brian has played critical roles in notable companies such as Biogen MA Inc. and Sunesis Pharmaceuticals, Inc. His expertise in drug development and invention has allowed him to influence the pharmaceutical landscape significantly, driving forward the discovery of new treatments and improving patient outcomes.

Collaborations: Collaboration has been a key element of Hopkins' career. He has worked alongside distinguished colleagues, including Patrick R. Conlon and Tracy J. Jenkins. Together, they have contributed to advancing research and development in their field, demonstrating the power of teamwork in innovation.

Conclusion: Brian T. Hopkins stands out as a pivotal inventor within the pharmaceutical industry. His extensive patent portfolio and collaborations reflect his commitment to innovation and improving healthcare solutions. As he continues to develop new therapeutics, Hopkins inspires the next generation of inventors in the field.

This text is generated by artificial intelligence and may not be accurate.